Contributions of myofascial pain in diagnosis and treatment of shoulder pain

Effectiveness in the treatment of Subacromial Impingement Syndrome by dry needling of active myofascial trigger points: a randomised controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN30907460

Enrollment

132

Registered

2009-02-27

Start date

2008-10-01

Completion date

Unknown

Last updated

2019-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myofascial pain, shoulder pain, subacromial impingement syndrome Musculoskeletal Diseases Shoulder lesions

Interventions

Five health centres in the city of Zaragoza take part in this study. In the randomise controlled trial, the subjects included in the study will be randomised (with a hidden sequence)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients belonging to five health centres in the city of Zaragoza (Spain) 2. Both males and females, over the age of 18 3. Diagnosis of rotator cuff tendonitis and/or SIS by GP 4. Functional limitation and pain above 50% of the range of movement in flexion, abduction in the scapular plane and outward medial rotation 5. Patients who give their consent after being informed about participation in the study

Exclusion criteria

Exclusion criteria: 1. Previous surgery for SIS 2. Invalidity, pain or sudden loss of strength after suffering a traumatism that suggests another serious condition 3. Other red flag signs indicating systemic disease 4. Inability to attend intervention sessions or refusal to participate

Design outcomes

Primary

Measure	Time frame
1. Joint restriction measured by inclinometer: flexion-extension movements, abduction-adduction movements and outward-inward rotation movements 2. Pain on elevation in the scapular plane measured by score on Visual Analogical Scale and location of pain 3. Existence of active MTrPs in supraspinatus, infraspinatus, subscapularis and teres minor measured by algometry 4. Function Constant Test The outcomes above will be assessed at the following time-points: T0: At the beginning of the study (inclusion point) T1: At the end of treatment (after 15 physiotherapy sessions) T2: 3 months after the end of treatment	—

Measure

Time frame

1. Joint restriction measured by inclinometer: flexion-extension movements, abduction-adduction movements and outward-inward rotation movements 2. Pain on elevation in the scapular plane measured by score on Visual Analogical Scale and location of pain 3. Existence of active MTrPs in supraspinatus, infraspinatus, subscapularis and teres minor measured by algometry 4. Function Constant Test The outcomes above will be assessed at the following time-points: T0: At the beginning of the study (inclusion point) T1: At the end of treatment (after 15 physiotherapy sessions) T2: 3 months after the end of treatment

—

Secondary

Measure	Time frame
No secondary outcome measures	—

Countries

Spain

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 28, 2026